Eating disorders in phenylketonuria patients study
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at eating habits and disorders in people with phenylketonuria (PKU) who are treated at a specific hospital in Nancy, France. Participating involves sharing information, which may help doctors better understand eating challenges in PKU.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have PKU (phenylketonuria)
- You are being followed at Nancy University Hospital in France
- You are willing to take part in the study
- You have not decided not to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a phenylalanine-restricted diet or certain PKU medicines affect gut health in children with PKU. It also includes healthy siblings or household members as a comparison group.
This study looks at how different meals eaten before exercise affect amino acid levels and metabolic health in adults with classic phenylketonuria (PKU)—a genetic condition affecting how your body processes protein. The research involves eating test meals, exercising, and providing blood samples to help understand the best nutritional approach for PKU patients.
This study looks at how educational, social support, and nutrition help affect pregnancy outcomes and quality of life in women with PKU. It may help you better manage PKU-related needs before and during pregnancy.
This trial tests an investigational drug (AG-181) for people with PKU who have a specific genetic change (R408W mutation). It aims to check if the drug is safe and how it works in your body.
This study talks to parents or doctors about how they first learned their child had PKU through newborn screening. It aims to improve how these rare metabolic diseases are communicated to families.
This study looks at whether following specific care guidelines for phenylketonuria (PKU) leads to better metabolic control (blood phenylalanine levels) and better patient well-being. You may be asked to complete questionnaires and follow the study plan while receiving the usual PKU treatment your clinic recommends.
Hear when a new Phenylketonuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.